#RevolutionMedicines is likely just weeks away from getting #EU approval for its oral #RASinhibitor #Rasonque as a treatment for #pancreaticcancer, after the drug was recommended by the #EMA's human medicines committee.

pharmaphorum.com/news/revmed-...